OTLC

$0.03-$0.00 (-6.67%)live

Compare

Change$-0.14

Fair-value model

Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.

Years of analysisAssumption entries

Analyst estimates unavailable for this ticker.

Held by

portfolios on TandT

Bookmarked by

users

Avg position size

—

of holders' portfolios

13F filers

institutions

52-week range

$0.02 – $0.11

14% from low

Exchange

OTC Link

P/E LTM (FWD)

0.0 (—)

Run the fair-value model →

P/S (TTM)

52.4

Earnings surprises

Beat consensus in 3 of the last 3 reported quarters

Reported	Est. EPS	Actual	Surprise
2026-08-13	$-0.02	$0.00	+104.5%
2026-05-14	$-0.02	$-0.00	+75.5%
2026-04-15	$-0.02	$0.59	+3050.0%

Peer comparison

Symbol	Price	Today	Mkt cap	P/E
OTLCOncotelic Therapeutics, Inc.	$0.03	-6.67%	$12M	—
ACHFFArch Biopartners Inc.	$0.62	-4.53%	$42M	—
BLOZFCannabix Technologies Inc.	$0.29	-4.32%	$35M	—
CVALFCovalon Technologies Ltd.	$2.53	-1.17%	$70M	—
CXXIFC21 Investments Inc.	$0.26	-0.11%	$31M	—
HBPCFHelix BioPharma Corp.	$1.71	+0.00%	$131M	—
INNMFAmplia Therapeutics Limited	$0.08	-9.28%	$42M	—

Source: Financial Modeling Prep · peers by sector/industry

ONCOTELIC THERAPEUTCS INC

Held by traders on TradeandTell

No one on the platform currently holds OTLC.

Super investors & insiders

Institutions holding (13F)

No tracked institution reports a position in OTLC as of their last filing.

Insider activity (SEC Form 4)

Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.

Insider activity (SEC Form 4)

Recent trades on TradeandTell

No one on the platform has traded OTLC yet.

$OTLC chatter on StockTwits

Sam@MauisurfriderBearishSep 8
$OTLC Hey Trieu what happened to all your paid pumper articles on Yahoo?????Didnt pay your bill with them either? Last raise was nail in the coffin here. Trieu headed overseas with investors cash. Wheres you Hong Kong IPO. Still sittimg around laughing about scamming investors with poopoo coins.
View on StockTwits ↗
Sam@MauisurfriderBearishSep 2
$OTLC Old scam Trieu must have quit paying the PR pumper companies to promote his POS. DOESNT PAY HIS BILLS BUT HAS MONEY FOR PR????? PONZI, SEND HIM TO JAIL BEFORE HE LEAVES THE COUNTRY!!
View on StockTwits ↗
Sam@MauisurfriderBearishSep 2
$OTLC Time for another company name change! SCAM TRIEU GONNA HAVE TO ANSWER TO THE INVESTORS HE SCAMMED!! Going to ZERO, SELL SELL SELL!! LAST ROUND OF MONEY RAISE HE MADE THE MISTAKE OF LETTING THEM CONVERT AT 85%, THAT WAS THE DEATH OF THIS SCAM.
View on StockTwits ↗
Stalone@Sho141Aug 29
@geegor I’m still bullish but man $OTLC taught me a big lesson 😂 I’ve set my mind on most likely not seeing profit till Next year Summer or Fall. 😩
View on StockTwits ↗
David stone@BunsterAug 26
$OTLC HEY CONDOC HOW MANY WEEKS UNTIL THE NEXT TOXIC CONV DEBT RAISE???????????????????????????????????????????
View on StockTwits ↗
David stone@BunsterAug 26
$OTLC
View on StockTwits ↗
Sam@MauisurfriderBearishAug 26
$OTLC BETTER CONVERT YOUR SHARES AND SELL, 85% OF YOUR MONEY IS BETTER THAN 0 IF YOU WERE PART OF THE LAST FUNDING ROUND. TRIEU HAS BEEN SCAMMING FOR 20 YEARS, NEVER DONE ANYTHING MEANINGFUL EXCEPT POOPOO TOKENS.
View on StockTwits ↗
Sam@MauisurfriderBearishAug 26
$OTLC BORROWS MONEY EVERYWHERE AND THEN JUST SPENDS IT ON PR COMPANIES AND BOTS.....WHERES THE PET DOO DOO TOKENS, AI REVOLUTIONARY TECH, BLAH BLAH BLAH. TRIEU AND HIS FAMILY SPEND ALL DAY ON THE NEXT SCAM!! JAILTIME!!
View on StockTwits ↗
Sam@MauisurfriderBearishAug 26
$OTLC BK IN 2027 WHEN MULTIPLE ROUNDS OF DEBT MATURE
View on StockTwits ↗
David stone@BunsterAug 20
$OTLC MORE TOXIC DEBT GOOD JOB SCAMDOC
View on StockTwits ↗
David stone@BunsterAug 20
$OTLC MANY FIGURED THAT OUT A LONG LONG TIME AGO. FROM OXIGENE DAYS LOLLOL
View on StockTwits ↗
Sam@MauisurfriderBearishAug 7
$OTLC People finally figuring out Dr Scam Trieu
View on StockTwits ↗
Chris Ruel@ckruelAug 4
$OTLC another financing… https://tipranks.onelink.me/WJho/141idj3x
View on StockTwits ↗
David Shapiro@B2iDigitalAug 4
Oncotelic Therapeutics, Inc. (OTCQB: $OTLC ) presents at the OTCQB Virtual Investor Conference at 2:30 PM ET on Thursday, August 6, 2026. The OTCQB Virtual Investor Conference is a B2i Digital Featured Conference. For more details, please visit: https://b2idigital.com/vic-august-5th-and-6th-otcqb-virtual-investor-conference To register and view the presentation: https://www.virtualinvestorconferences.com/wcc/eh/4814904/lp/5436153/oncotelic-therapeutics-inc-otcqb-otlc?utm_source=b2i&utm_medium=marketing&utm_campaign=0806AugOTCQBVIC Request a one-on-one meeting: https://app.axleaccess.com/public/events/a423dcfc-dcb6-434d-a717-92e0c2bd482c?token=bed16a45-7c55-4efb-a23e-3321c2e5a7e0 Oncotelic Therapeutics is a clinical-stage biopharmaceutical company focused on the development of oncology and immunotherapy products, with a stated mission to address high-unmet-need cancers and rare pediatric indications with late-stage therapeutic candidates. Beyond its internal programs, the Company licenses and co-develops select drug candidates through joint ventures, owns 45% of the GMP Bio joint venture, and develops PDAOAI, its proprietary artificial intelligence platform for drug discovery, cleanroom automation, and AI-assisted GMP manufacturing. Learn more at [www.oncotelic.com/investors](https://www.oncotelic.com/investors/). Virtual Investor Conferences is an OTC Markets Group Inc. property. Learn more at www.virtualinvestorconferences.com. Discover more emerging growth Featured Companies, industry-leading Featured Experts, and upcoming Featured Conferences at https://b2idigital.com. @B2iDigital is the Official Marketing Partner of Virtual Investor Conferences. Content is informational only and is not investment advice. B2i Digital is not a broker-dealer or investment adviser.
View on StockTwits ↗
David Shapiro@B2iDigitalAug 4
Oncotelic Therapeutics, Inc. (OTCQB: $OTLC ) presents at the OTCQB Virtual Investor Conference at 2:30 PM ET on Thursday, August 6, 2026. The OTCQB Virtual Investor Conference is a B2i Digital Featured Conference. For more details, please visit: https://b2idigital.com/vic-august-5th-and-6th-otcqb-virtual-investor-conference To register and view the presentation: https://www.virtualinvestorconferences.com/wcc/eh/4814904/lp/5436153/oncotelic-therapeutics-inc-otcqb-otlc?utm_source=b2i&utm_medium=marketing&utm_campaign=0806AugOTCQBVIC Request a one-on-one meeting: https://app.axleaccess.com/public/events/a423dcfc-dcb6-434d-a717-92e0c2bd482c?token=bed16a45-7c55-4efb-a23e-3321c2e5a7e0 Oncotelic Therapeutics is a clinical-stage biopharmaceutical company focused on the development of oncology and immunotherapy products, with a stated mission to address high-unmet-need cancers and rare pediatric indications with late-stage therapeutic candidates. Beyond its internal programs, the Company licenses and co-develops select drug candidates through joint ventures, owns 45% of the GMP Bio joint venture, and develops PDAOAI, its proprietary artificial intelligence platform for drug discovery, cleanroom automation, and AI-assisted GMP manufacturing. Learn more at [www.oncotelic.com/investors](https://www.oncotelic.com/investors/). Virtual Investor Conferences is an OTC Markets Group Inc. property. Learn more at www.virtualinvestorconferences.com. Discover more emerging growth Featured Companies, industry-leading Featured Experts, and upcoming Featured Conferences at https://b2idigital.com. @B2iDigital is the Official Marketing Partner of Virtual Investor Conferences. Content is informational only and is not investment advice. B2i Digital is not a broker-dealer or investment adviser.
View on StockTwits ↗

Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.